Ultra-high-resolution cardiac CT with NAEOTOM Alpha before TAVI
Official title: Prospective Registry of Patients Undergoing Cardiac CT With NAEOTOM Alpha Photon Counting-detector CT Before Transcatheter Aortic Valve Implantation
Run by Semmelweis University · NCT07016477 · Data updated 2026-11-12
This study will test whether ultra-high-resolution photon-counting CT can accurately detect coronary artery disease in patients having TAVI and potentially reduce the need for invasive coronary angiography.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Semmelweis University Academic / other |
| Locations | 7 sites (Charleston, South Carolina and 6 other locations) |
| Status | Recruiting |
| Started | June 1, 2024 |
| Main results expected | May 30, 2029 |
| Study ends | May 30, 2030 |
| Registry record updated | June 11, 2025 |
| Trial ID | NCT07016477 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients planned for TAVI who can undergo both CT angiography and invasive coronary angiography, have acceptable kidney function (eGFR ≥30 ml/min/1.73m2), and can provide informed consent.
✕Probably not a fit
Patients with severe chronic renal failure, those who are pregnant or breastfeeding, on active oncologic treatment, or those for whom TAVI or CT angiography is contraindicated are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an international, prospective multicenter registry enrolling patients scheduled for transcatheter aortic valve implantation who are also undergoing clinically indicated coronary CT and invasive coronary angiography. Participants receive ultra-high-resolution photon-counting detector (PCD) coronary CT with the NAEOTOM Alpha prior to TAVI, and imaging results are compared to invasive coronary angiography to determine feasibility and diagnostic accuracy. The registry captures clinical and demographic factors, image quality metrics, and concordance with invasive angiography across multiple centers. Key exclusions include severe renal impairment, pregnancy, active oncologic treatment, or any condition that contraindicates TAVI or CT angiography.
Why it matters
Potential benefit: If successful, this approach could give frail TAVI patients more precise noninvasive coronary imaging and reduce the need for invasive angiography.
How similar studies have gone: Conventional CT coronary angiography has shown diagnostic utility in some TAVI populations, but ultra-high-resolution photon-counting CT is relatively new and currently supported mainly by limited pilot and technical studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Clinically indicated TAVI * Clinically indicated CT and invasive coronary angiography * There are no contraindications to CT angiography. * Understanding and signing the consent form Exclusion Criteria: * Pregnancy or breastfeeding * Chronic renal failure (eGFR \<30 ml/m2) * Active oncological treatment * Any condition for which TAVI is contraindicated and therefore no prior radiological investigation of TAVI is indicated
Where it's running
-
Medical University of South Carolina
Charleston, South Carolina, United States Recruiting -
University Medical Center Mainz
Mainz, Germany Recruiting -
Semmelweis University
Budapest, Hungary Recruiting -
Albert-Ludwigs-Universität Freiburg
Freiburg im Breisgau, Germany Not yet recruiting -
Universitätsklinikum Tübingen
Tübingen, Germany Not yet recruiting -
Maastricht University
Maastricht, Netherlands Not yet recruiting
Show 1 more location
-
University Hospital of Zürich
Zurich, Switzerland Not yet recruiting
Study contacts
- Principal investigator: Pál Maurovich-Horvat, MD, PhD, DSc — Semmelweis University
- Study coordinator: Pál Maurovich-Horvat, MD, PhD, DSc
- Email: maurovich-horvat.pal@semmelweis.hu
- Phone: +3614591500
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing minimal invasive extracorporeal circulation to conventional cardiopulmonary bypass in heart surgery
This study is testing if a new heart surgery method called minimal invasive extracorporeal circulation can help patients avoid serious complications better than the traditional method.
-
Examining heart blood flow in patients with severe aortic valve narrowing
This study tests how two heart flow measurements can help doctors understand and treat patients with severe aortic valve narrowing and coronary artery disease.
-
A quick 10-minute heart scan for cardiac diseases
This study is testing a quick 10-minute heart scan to see if it can help diagnose heart problems better and faster for many patients without needing special dyes.
-
Personalized activity intervention for patients recovering from heart surgery
This study is testing whether a personalized activity program can help patients recovering from heart surgery feel better and recover faster compared to standard rehabilitation.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
-
Transcatheter Aortic Valve Replacement Registry for Outcomes and Quality Monitoring
This registry collects information from hospitals about patients undergoing TAVR to see how care and outcomes compare to guidelines and nationwide data.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.